Role of splenic and bone marrow uptake at
18F-FDG
positron emission tomography
spleen
vasculitis
Journal
Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
16
02
2023
accepted:
04
07
2023
medline:
1
11
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
To assess the relationship between splenic and bone marrow (BM) uptake with the presence of large vessel vasculitis (LVV) at One hundred and one subjects with LVV and Significant correlation for PET/CT results with spleen uptake (P-value = 0.001), SL (P-value < 0.001) and BML (P-value = 0.005) were reported in patients with no more than 3 days of therapy; the correlation with SL was confirmed in the total cohort of patients. A value of 0.92 for SL had an AUC of 0.959, a sensitivity of 92.6% and a specificity of 96.6% (P-value < 0.001) in predicting PET/CT results. Higher splenic and BM uptake in patients with positive PET/CT for LVV were reported. A long duration of GC therapy is able to reduce such uptakes.
Identifiants
pubmed: 37469123
doi: 10.1111/1754-9485.13560
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Glucocorticoids
0
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
717-725Informations de copyright
© 2023 The Royal Australian and New Zealand College of Radiologists.
Références
Pelletier-Galarneau M, Ruddy TD. PET/CT for diagnosis and management of large-vessel vasculitis. Curr Cardiol Rep 2019; 21: 34.
Pugh D, Karabayas M, Basu N et al. Large-vessel vasculitis. Nat Rev Dis Primers 2022; 7: 93.
Comarmond C, Biard L, Lambert M et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients. Circulation 2017; 136: 1114-1122.
Salvarani C, Cantini F, Boiardi L, Hunder G. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003; 21 (6 Suppl 32): S23-S28.
Dejaco C, Ramiro S, Duftner C et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018; 77: 636-643.
Casali M, Lauri C, Altini C et al. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021; 9: 299-339.
Albano D, Dondi F, Gazzilli M, Giubbini R, Bertagna F. Meta-analysis of the diagnostic performance of 18F-FDG-PET/CT imaging in native valve endocarditis. JACC Cardiovasc Imaging 2021; 14: 1063-1065.
Dondi F, Albano D, Bellini P, Volpi G, Giubbini R, Bertagna F. 18F-fluorodeoxyglucose PET and PET/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review. Nucl Med Commun 2022; 43: 638-645.
Treglia G, Albano D, Dondi F, Bertagna F, Gheysens O. A role of [18F]FDG PET/CT for response assessment in large vessel disease? Semin Nucl Med 2022; 53: 78-85.
Dondi F, Albano D, Cerudelli E et al. Radiolabelled PSMA PET/CT or PET/MRI in hepatocellular carcinoma (HCC): a systematic review. Clin Transl Imaging 2020; 8: 461-467.
Slart RHJA, Writing Group, Reviewer Group et al. FDG-PET/CT (A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 2018; 45: 1250-1269.
Cheng Y, Lv N, Wang Z, Chen B, Dang A. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 2013; 31 (1 Suppl 75): S22-S27.
Dellavedova L, Carletto M, Faggioli P et al. The prognostic value of baseline 18-FFDG PET/CT in steroid-naive large-vessel vasculitis: introduction of volume-based parameters. Eur J Nucl Med Mol Imaging 2016; 43: 340-348.
Yao Y, Cheng J, Su M, Ou X. Effects of fever on 18F-FDG distribution in vivo: a preliminary study. Mol Imaging Biol 2020; 22: 1116-1123.
Rosenblum JS, Quinn KA, Rimland CA, Mehta NN, Ahlman MA, Grayson PC. Clinical factors associated with time-specific distribution of 18F-fluorodeoxyglucose in large-vessel vasculitis. Sci Rep 2019; 9: 15180.
Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol 2015; 67: 3190-3200.
Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity 2013; 39: 806-818.
Patel NH, Osborne MT, Teague H et al. Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: an observational study. Atherosclerosis 2021; 339: 20-26.
Toutouzas K, Skoumas J, Koutagiar I et al. Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia. J Clin Lipidol 2018; 12: 33-43.
Pijl JP, Kwee TC, Slart RHJA, Yakar D, Wouthuyzen-Bakker M, Glaudemans AWJM. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia. Eur J Nucl Med Mol Imaging 2021; 48: 1467-1477.
Kaiser H, Kvist-Hansen A, Krakauer M et al. Association between vascular inflammation and inflammation in adipose tissue, spleen, and bone marrow in patients with psoriasis. Life (Basel) 2021; 11: 305.
Zhao E, Xu H, Wang L et al. Bone marrow and the control of immunity. Cell Mol Immunol 2012; 9: 11-19.
Boursier C, Duval X, Mahida B et al. Hypermetabolism of the spleen or bone marrow is an additional albeit indirect sign of infective endocarditis at FDG-PET. J Nucl Cardiol 2021; 28: 2533-2542.
Lee JH, Lee HS, Kim S et al. Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer. Sci Rep 2021; 11: 12137.
Ishibashi M, Norikane T, Yamamoto Y et al. Correlation of bone marrow 2-deoxy-2-[18F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer. Nucl Med Commun 2022; 43: 916-921.
Nam HY, Kim SJ, Kim IJ, Kim BS, Pak K, Kim K. The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance. Clin Nucl Med 2010; 35: 759-763.
Kim K, Kim SJ, Kim IJ et al. Factors associated with diffusely increased splenic F-18 FDG uptake in patients with cholangiocarcinoma. Nucl Med Mol Imaging 2014; 48: 137-143.
Ahn SS, Hwang SH, Jung SM et al. Evaluation of spleen glucose metabolism using 18F-FDG PET/CT in patients with febrile autoimmune disease. J Nucl Med 2017; 58: 507-513.
Kashiwazaki D, Yamamoto S, Akioka N, Kuwayama N, Noguchi K, Kuroda S. Inflammation coupling between unstable carotid plaque and spleen-a 18F-Fluorodeoxyglucos positron emission tomography study. J Stroke Cerebrovasc Dis 2018; 27: 3212-3217.
Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5: 606-616.